Braze Mobility was awarded AGE-WELL's newly launched Emerging Entrepreneur Award, a salary award for those seeking to turn their innovation into a viable business through a start-up company. 

Conavi Medical announced that Japan Lifeline, their exclusive distributor, has submitted an application for the regulatory approval of the NovaSight Hybrid intravascular imaging system in Japan.

Starting in March 2019, Carleton Physics Prof. Manuella Vincter will be the Deputy Spokeperson of the ATLAS project, the largest particle detector ever built and one of four major experiments at the Large Hadron Collider particle accelerator.

Connection Silicon Valley, which helps Canadian startups connect with the Silicon Valley ecosystem, has announced that applications are now open for the Canadian Women’s Network Fall Cohort.

The Centre for Commercializing Regenerative Medicine (CCRM) and the University Health Network (UHN) have opened a new Centre for Cell and Vector Production which will produce clinical-grade cells and viral vectors for Phase 1 and 2 clinical trials. 

iBionics received a $5,000 grant from the Women Founders Fund, which aims to alleviate some of the financial barriers women in the STEM industry face when starting and accessing opportunities for business and professional growth.

Flosonics was named a finalist for 2018 Ontario Centres of Excellence Martin Walmsley Award for Entrepreneurship, which carried a prize of $25,000.

RetiSpec will collaborate with the University of Minnesota to commercialize their technology for early detection of Alzheimer’s disease.

TR Talks is hosted by the University of Toronto's Translational Research Program (TRP) and is intended to provoke discussion and community building. The next talk will be October 30th on the topic of "Pathways to Market: Post clinical trials." 

The Consulate General of Canada in Chicago, in partnership with the Chicago Innovation Mentors (CIM), is offering the opportunity to participate in a comprehensive mentoring program to five Canadian life science and healthcare start-ups.

Through the partnership, Stryker's will offer Synaptive’s BrightMatter™ Plan software, which automatically generates high-fidelity, dynamic, whole-brain tractography. 

ManagingLife's CEO Tahir Janmohamed discussed recent partnerships and plans for the future in an article titled, "Biomedical Zone gives startups place to validate in clinical settings."

The Synapse Life Science Competition is designed to help move innovative life science products and services out of the lab and into the market. The top-ranked teams will deliver a business pitch, competing for up to $60,000 in cash and in-kind prizes.

The 2018 Nobel Prize in Physics was awarded jointly to Canadian Donna Strickland and co-laureate Gérard Mourou, whose research paved the way towards the shortest and most intense laser pulses created by humankind. Dr. Strickland is an associate professor at the University of Waterloo, and is one of three women to receive the Nobel Prize in Physics.

The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest, has announced support for the development and validation testing of 31 new innovations in aging and brain healthcare, resulting in a total of $1.4 M in support through CABHI’s Spark program.

Vasomune Therapeutics, a leading biotechnology company developing therapeutics targeting vascular dysfunction and inflammation, announced that Douglas A. Hamilton has been appointed President and Chief Executive Officer of the company.

Syng Pharmaceuticals is working with the Impact Centre to develop a new non-invasive diagnostic test for endometriosis, an immunologic condition affecting one in ten women.

The University of Waterloo announced a 4-year, $400,000 partnership with Manulife Financial to support artificial intelligence research in disability claim prediction as well as fraud detection and natural language comprehension in customer service.

Cyclica announced a multi-phase collaboration with Eurofarma to advance drug discovery programs by driving insights into small molecule polypharmacology.